Hidradenitis Suppurativa
Symptoms, Doctors, Treatments, Advances & More

Save information for later
Sign Up

Learn About Hidradenitis Suppurativa

What is the definition of Hidradenitis Suppurativa?

Hidradenitis suppurativa, also known as acne inversa, is a chronic skin disease characterized by recurrent boil-like lumps (nodules) under the skin. The nodules become inflamed and painful. They tend to break open (rupture), causing abscesses that drain fluid and pus. As the abscesses heal, they produce significant scarring of the skin.

What are the causes of Hidradenitis Suppurativa?

In most cases, the cause of hidradenitis suppurativa is unknown. The condition probably results from a combination of genetic and environmental factors. Originally, researchers believed that the disorder was caused by the blockage (occlusion) of specialized sweat glands called apocrine glands. However, recent studies have shown that the condition actually begins with a blockage of hair follicles in areas of the body that also contain a high concentration of apocrine glands (such as the armpits and groin). The hair follicles have a buildup of a fibrous protein called keratin (hyperkeratosis). The blocked hair follicles trap bacteria, leading to inflammation and rupture. Researchers have several ideas about what initially causes the follicles to become blocked and why the nodules tend to recur, but the causes remain unclear.

How prevalent is Hidradenitis Suppurativa?

Hidradenitis suppurativa was once thought to be a rare condition because only the most severe cases were reported. However, recent studies have shown that the condition affects at least 1 in 100 people when milder cases are also considered. For reasons that are unclear, women are more commonly affected than men.

Is Hidradenitis Suppurativa an inherited disorder?

Hidradenitis suppurativa has been reported to run in families. Studies have found that 30 to 40 percent of affected individuals have at least one family member with the disorder. However, this finding may be an underestimate because affected individuals do not always tell their family members that they have the condition, and hidradenitis suppurativa is sometimes misdiagnosed as other skin disorders.

Who are the top Hidradenitis Suppurativa Local Doctors?
Afsaneh Alavi
Elite in Hidradenitis Suppurativa
Dermatology
Elite in Hidradenitis Suppurativa
Dermatology

Mayo Clinic-Rochester

5716 Cleveland St Ste 200, 
Virginia Beach, VA 
Languages Spoken:
English

Afsaneh Alavi is a Dermatologist in Virginia Beach, Virginia. Dr. Alavi is rated as an Elite provider by MediFind in the treatment of Hidradenitis Suppurativa. Her top areas of expertise are Hidradenitis Suppurativa, Pyoderma Gangrenosum, Livedo Reticularis, and Erythema Nodosum.

John Frew
Elite in Hidradenitis Suppurativa
Dermatology
Elite in Hidradenitis Suppurativa
Dermatology

Rockefeller University Hospital

1230 York Ave, 
New York, NY 
Languages Spoken:
English

John Frew is a Dermatologist in New York, New York. Dr. Frew is rated as an Elite provider by MediFind in the treatment of Hidradenitis Suppurativa. His top areas of expertise are Hidradenitis Suppurativa, Pyoderma Gangrenosum, Acne, Epidermolysis Bullosa, and Tissue Biopsy.

 
 
 
 
Learn about our expert tiers
Learn More
Martina J. Porter
Elite in Hidradenitis Suppurativa
Elite in Hidradenitis Suppurativa

Beth Israel Deaconess Medical Center

330 Brookline Avenue, Shapiro 2, 
Boston, MA 
Languages Spoken:
English
Offers Telehealth

Martina Porter is a Dermatologist in Boston, Massachusetts. Dr. Porter is rated as an Elite provider by MediFind in the treatment of Hidradenitis Suppurativa. Her top areas of expertise are Hidradenitis Suppurativa, Psoriasis, Acne, and Pyoderma Gangrenosum.

What are the latest Hidradenitis Suppurativa Clinical Trials?
A Phase 2, Open-Label Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Povorcitinib in Adolescents With Moderate to Severe Hidradenitis Suppurativa

Summary: The purpose of this study is to evaluate the pharmacokinetics, safety, and efficacy of povorcitinib in adolescent participants with moderate to severe hidradenitis suppurativa over a 54-week open-label treatment period.

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase 2, Multi-Center Study Consisting of a Randomized, Placebo-Controlled Period, Followed by an Open-Label Extension Period to Assess the Efficacy, Safety, and Tolerability of Tibulizumab in Adults With Hidradenitis Suppurativa

Summary: The study is a Phase 2, multi-center, randomized, double-blind, placebo-controlled study to evaluate the effects of tibulizumab over 16 weeks (Period 1) in adults with hidradenitis suppurativa, followed by a 16-week open-label extension period in which all participants will receive tibulizumab (Period 2)

Who are the sources who wrote this article ?

Published Date: October 27, 2021
Published By: National Institutes of Health